In the latest trading session, Medtronic (MDT) closed at $88.58, marking a +1.04% move from the previous day. This change outpaced the S&P 500's 0.07% loss on the day. Elsewhere, the Dow saw a ...

Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots ...

Deal Rationale Medtronic, a global leader in MedTech, is planning to spin off its Diabetes business into a standalone entity, as part of a strategic move to sharpen its focus on higher-margin ...

The Medtronic site isn’t the only candidate for redevelopment in Columbia Heights. Most notably, Finance & Commerce reported in 2021 that Alatus paid $4.5 million for a largely vacant shopping ...

Medtronic reported a fourth quarter global revenue of nearly $9 billion on Wednesday, totaling more than $33.5 billion globally for fiscal year 2025.

Medical-device maker Medtronic MDT -0.13% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

According to Focus Report Store, the global insulin pump market is growing at a CAGR of 9.10% during 2024-2030. The insulin pumps market is experiencing significant growth, driven by the rising ...

Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances. These favorable returns have had a median of 2.5% and a ...

The Galway native who previously served as Vice President of Medtronic’s Worldwide Operations has taken up a new role as Chief Operating Officer with a new MedTech multi-national that is providing ...